Articles

ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal. More

Bitcoin has plenty of overhead room to rally as the $69,000 resistance level is destined to be overcome in 2024. More

HOOD stock is climbing and trending on social media after Robinhood announced that it would enter the U.K. market. More

These lesser known companies have been outperforming the market in recent months and there looks to be a tailwind behind their shares. More

VFS has 2.33 billion shares outstanding but just 34.75 million in its public float, A big short interest makes VFS stock quite volatile. More

Redhill Biopharma stock is falling on Thursday as shares of RDHL give up some of the gains they made throughout the week. More

There have not been many successful IPOs in 2023, so finding stock picks from the Renaissance IPO ETF won’t be easy. More

Subscriber Sign in